Clinical Trial Update: Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD [Phase 3]

View source ↗

Summary

A Phase 3 trial update reports on the efficacy and safety of tiotropium inhalation capsules in patients with chronic obstructive pulmonary disease, including 24…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Spiriva (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: COMPLETED